Heparin coating of the stent graft - Effects on platelets, coagulation and complement activation

Biomaterials

Volumn 22, Issue 4, 2001, Pages 349-355

  Christensen, Kjeld ^a   Larsson, Rolf ^b   Emanuelsson, Håkan ^a   Elgue, Graciela ^b   Larsson, Anders ^b  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coagulation; Heparin surface; In vitro study; Platelets; Stent

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; HEPARIN; THROMBIN ANTITHROMBIN COMPLEX;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STENT; THROMBOCYTE; THROMBOCYTE COUNT; ENZYME IMMUNOASSAY; LEUKOCYTE ACTIVATION; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION;

BIOCOMPATIBILITY; CELLS; PROTECTIVE COATINGS; PROTEINS; SCANNING ELECTRON MICROSCOPY; SURFACE PHENOMENA;

HEPARIN; PLATELETS; STENT GRAFTS;

GRAFTS;

BLOOD COAGULATION; COMPLEMENT ACTIVATION; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSCOPY, ELECTRON, SCANNING; NEUTROPHIL ACTIVATION; PLATELET ACTIVATION; PLATELET COUNT; STENTS;

EID: 0035864334     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00190-3     Document Type: Article

References (24)

1. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study
2. Angiographic follow-up after placement of a self-expanding coronary-artery stent
3. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty
4. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design
5. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
6. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
7. Mode of deployment of coronary Palmaz-Schatz stents after implantation with the stent delivery system: An intravascular ultrasound study
8. The JOSTENT coronary stent range
9. Heparin-coated coronary stents
10. Generation of iC3 at the interface between blood and gas
11. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
12. Balloon-expandable intracoronary stents in the adult dog
13. Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis
14. Small stent size and intimal hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis
15. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting
16. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil
17. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model
18. The three processes leading to post PTCA restenosis: Dependence on the lesion substrate
19. Restenosis after coronary angioplasty
20. Potential mechanisms promoting restenosis in diabetic patients
21. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries
22. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study
23. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)